Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis.
Marques
M
M
Magro
F
F
Cardoso
H
H
Carneiro
F
F
Portugal
R
R
Lopes
J
J
Costa Santos
C
C
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D001706:Biopsy; D003093:Colitis, Ulcerative / Q000188:drug therapy; D003937:Diagnosis, Differential; D005260:Female; D019693:Hepatitis, Autoimmune / Q000209:etiology* / Q000473:pathology; D006801:Humans; D000069285:Infliximab; D008099:Liver / Q000473:pathology; D008177:Lupus Vulgaris / Q000139:chemically induced* / Q000175:diagnosis; D013577:Syndrome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab